490 related articles for article (PubMed ID: 28495456)
1. Crosstalk between STAT5 activation and PI3K/AKT functions in normal and transformed mammary epithelial cells.
Rädler PD; Wehde BL; Wagner KU
Mol Cell Endocrinol; 2017 Aug; 451():31-39. PubMed ID: 28495456
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of JAK2 in mammary epithelium elevates Stat5 signalling, promotes alveologenesis and resistance to cell death, and contributes to tumourigenesis.
Caffarel MM; Zaragoza R; Pensa S; Li J; Green AR; Watson CJ
Cell Death Differ; 2012 Mar; 19(3):511-22. PubMed ID: 21941370
[TBL] [Abstract][Full Text] [Related]
3. Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression.
Wagner KU; Rui H
J Mammary Gland Biol Neoplasia; 2008 Mar; 13(1):93-103. PubMed ID: 18228120
[TBL] [Abstract][Full Text] [Related]
4. Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesis.
Schmidt JW; Wehde BL; Sakamoto K; Triplett AA; Anderson SM; Tsichlis PN; Leone G; Wagner KU
Mol Cell Biol; 2014 Apr; 34(7):1363-77. PubMed ID: 24469394
[TBL] [Abstract][Full Text] [Related]
5. Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1.
Creamer BA; Sakamoto K; Schmidt JW; Triplett AA; Moriggl R; Wagner KU
Mol Cell Biol; 2010 Jun; 30(12):2957-70. PubMed ID: 20385773
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
[TBL] [Abstract][Full Text] [Related]
7. CUZD1 is a critical mediator of the JAK/STAT5 signaling pathway that controls mammary gland development during pregnancy.
Mapes J; Li Q; Kannan A; Anandan L; Laws M; Lydon JP; Bagchi IC; Bagchi MK
PLoS Genet; 2017 Mar; 13(3):e1006654. PubMed ID: 28278176
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-221 regulates proliferation of bovine mammary gland epithelial cells by targeting the STAT5a and IRS1 genes.
Jiao BL; Zhang XL; Wang SH; Wang LX; Luo ZX; Zhao HB; Khatib H; Wang X
J Dairy Sci; 2019 Jan; 102(1):426-435. PubMed ID: 30366615
[TBL] [Abstract][Full Text] [Related]
9. ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation.
Williams MM; Vaught DB; Joly MM; Hicks DJ; Sanchez V; Owens P; Rahman B; Elion DL; Balko JM; Cook RS
Breast Cancer Res; 2017 Sep; 19(1):105. PubMed ID: 28886748
[TBL] [Abstract][Full Text] [Related]
10. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
[TBL] [Abstract][Full Text] [Related]
11. Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.
Furth PA; Nakles RE; Millman S; Diaz-Cruz ES; Cabrera MC
Breast Cancer Res; 2011 Oct; 13(5):220. PubMed ID: 22018398
[TBL] [Abstract][Full Text] [Related]
12. Akt is required for Stat5 activation and mammary differentiation.
Chen CC; Boxer RB; Stairs DB; Portocarrero CP; Horton RH; Alvarez JV; Birnbaum MJ; Chodosh LA
Breast Cancer Res; 2010; 12(5):R72. PubMed ID: 20849614
[TBL] [Abstract][Full Text] [Related]
13. Prolactin-stimulated activation of ERK1/2 mitogen-activated protein kinases is controlled by PI3-kinase/Rac/PAK signaling pathway in breast cancer cells.
Aksamitiene E; Achanta S; Kolch W; Kholodenko BN; Hoek JB; Kiyatkin A
Cell Signal; 2011 Nov; 23(11):1794-805. PubMed ID: 21726627
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis.
Mancini ML; Lien EC; Toker A
Oncotarget; 2016 Apr; 7(14):17301-13. PubMed ID: 27004402
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment with ruxolitinib and MK-2206 inhibits the JAK2/STAT5 and PI3K/AKT pathways via apoptosis in MDA-MB-231 breast cancer cell line.
Guvenir Celik E; Eroglu O
Mol Biol Rep; 2023 Jan; 50(1):319-329. PubMed ID: 36331743
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species via redox signaling to PI3K/AKT pathway contribute to the malignant growth of 4-hydroxy estradiol-transformed mammary epithelial cells.
Okoh VO; Felty Q; Parkash J; Poppiti R; Roy D
PLoS One; 2013; 8(2):e54206. PubMed ID: 23437041
[TBL] [Abstract][Full Text] [Related]
17. The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development.
Clarkson RW; Boland MP; Kritikou EA; Lee JM; Freeman TC; Tiffen PG; Watson CJ
Mol Endocrinol; 2006 Mar; 20(3):675-85. PubMed ID: 16293640
[TBL] [Abstract][Full Text] [Related]
18. Autocrine prolactin induced by the Pten-Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathways.
Chen CC; Stairs DB; Boxer RB; Belka GK; Horseman ND; Alvarez JV; Chodosh LA
Genes Dev; 2012 Oct; 26(19):2154-68. PubMed ID: 23028142
[TBL] [Abstract][Full Text] [Related]
19. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
Sultan AS; Brim H; Sherif ZA
Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926
[TBL] [Abstract][Full Text] [Related]
20. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.
He LF; Xu HW; Chen M; Xian ZR; Wen XF; Chen MN; Du CW; Huang WH; Wu JD; Zhang GJ
Oncotarget; 2017 Mar; 8(11):17573-17585. PubMed ID: 28407679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
